CALABRESI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 56.954
AS - Asia 4.881
EU - Europa 3.704
SA - Sud America 728
Continente sconosciuto - Info sul continente non disponibili 182
AF - Africa 49
OC - Oceania 8
Totale 66.506
Nazione #
US - Stati Uniti d'America 56.755
SG - Singapore 2.416
CN - Cina 967
UA - Ucraina 837
BR - Brasile 585
DE - Germania 575
HK - Hong Kong 555
RU - Federazione Russa 520
IE - Irlanda 469
IT - Italia 316
VN - Vietnam 312
SE - Svezia 244
FR - Francia 229
GB - Regno Unito 184
FI - Finlandia 169
KR - Corea 161
BD - Bangladesh 153
JP - Giappone 111
CA - Canada 78
PL - Polonia 59
AR - Argentina 55
IN - India 40
MX - Messico 32
ID - Indonesia 25
NL - Olanda 24
EC - Ecuador 20
JM - Giamaica 20
EU - Europa 19
CR - Costa Rica 18
TR - Turchia 18
CL - Cile 16
IQ - Iraq 14
SA - Arabia Saudita 14
ZA - Sudafrica 14
CO - Colombia 13
ES - Italia 13
KG - Kirghizistan 13
VE - Venezuela 13
MA - Marocco 10
UZ - Uzbekistan 10
PK - Pakistan 9
AT - Austria 8
CZ - Repubblica Ceca 8
MY - Malesia 8
PY - Paraguay 8
TT - Trinidad e Tobago 8
UY - Uruguay 8
AU - Australia 7
BE - Belgio 7
LT - Lituania 7
NI - Nicaragua 7
DZ - Algeria 6
GT - Guatemala 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
HN - Honduras 5
JO - Giordania 5
KE - Kenya 5
KZ - Kazakistan 5
NP - Nepal 5
PE - Perù 5
RO - Romania 5
CH - Svizzera 4
DM - Dominica 4
IR - Iran 4
NG - Nigeria 4
PR - Porto Rico 4
SV - El Salvador 4
TN - Tunisia 4
DK - Danimarca 3
EE - Estonia 3
GR - Grecia 3
MT - Malta 3
PT - Portogallo 3
TH - Thailandia 3
TW - Taiwan 3
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
BZ - Belize 2
EG - Egitto 2
GE - Georgia 2
GY - Guiana 2
IL - Israele 2
LB - Libano 2
LV - Lettonia 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
VG - Isole Vergini Britanniche 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
Totale 66.326
Città #
Woodbridge 17.723
Wilmington 14.505
Houston 12.885
Fairfield 1.675
Ann Arbor 1.322
Singapore 1.055
Ashburn 992
Jacksonville 777
Seattle 634
San Jose 581
Cambridge 574
Hong Kong 549
Dublin 469
Chandler 408
Medford 328
Beijing 297
Santa Clara 233
The Dalles 193
Lawrence 161
New York 161
Council Bluffs 137
Los Angeles 126
Zhengzhou 120
Mülheim 112
Ho Chi Minh City 104
Menlo Park 102
Buffalo 97
Tokyo 83
Dearborn 82
Moscow 79
Dallas 63
Rome 61
Hanoi 60
San Diego 57
São Paulo 57
Milan 51
Kraków 46
Lauterbourg 40
University Park 39
San Mateo 37
Shanghai 35
Mcallen 32
Hefei 31
Guangzhou 30
Mountain View 29
Orem 29
Falls Church 28
London 27
Munich 27
Verona 26
Atlanta 25
Saint Petersburg 24
Nanjing 22
Chicago 21
Detroit 20
Montreal 20
Brooklyn 19
Redwood City 19
Rio de Janeiro 19
Toronto 19
Frankfurt am Main 18
Palo Alto 18
Norwalk 17
Denver 16
Kingston 15
Brasília 14
Redondo Beach 14
San Francisco 14
Chennai 12
Monmouth Junction 12
North Bergen 12
Redmond 12
San José 12
Da Nang 11
Nuremberg 11
Belo Horizonte 10
Dhaka 10
Kunming 10
Manchester 10
Miami 10
Nanchang 10
Salvador 10
Warsaw 10
Biên Hòa 9
Boston 9
Columbus 9
Guayaquil 9
Haiphong 9
Hangzhou 9
Indiana 9
Johannesburg 9
Naples 9
Philadelphia 9
Florence 8
Jakarta 8
Phoenix 8
Porto Alegre 8
Stockholm 8
Tampa 8
Washington 8
Totale 58.011
Nome #
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 612
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 564
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 561
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 540
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 530
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 520
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 518
Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis 511
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 505
Synaptic transmission in the striatum: from plasticity to neurodegeneration 494
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 488
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 486
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 485
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 484
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 483
Muscarinic IPSPs in rat striatal cholinergic interneurones 482
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 476
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 474
The Project for a Scientific Psychology (1895): a Freudian anticipation of LTP-memory connection theory 473
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 472
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 471
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 470
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 469
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 467
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission 463
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine 462
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 461
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 461
Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons 460
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia 456
Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP 455
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease 454
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons 451
Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum 450
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons 448
Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation 446
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 446
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine 446
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation 445
NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum 445
NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease 444
Unilateral dopamine denervation blocks corticostriatal LTP 444
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 444
Synaptic plasticity in the ischaemic brain 443
Hyperkinetic disorders and loss of synaptic downscaling 443
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 441
Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity 439
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism 439
Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons 437
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors 437
Role of Ca2+ in striatal LTD and LTP 437
Long-term synaptic depression in the striatum: physiological and pharmacological characterization 437
Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity 436
Behavioural learning-induced increase in spontaneous GABAA-dependent synaptic activity in rat striatal cholinergic interneurons 436
Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity 435
Removing pathogenic memories: a neurobiology of psychotherapy 435
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine 435
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 435
L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases 434
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 433
Tissue plasminogen activator is required for corticostriatal long-term potentiation 433
Dopaminergic control of synaptic plasticity in the dorsal striatum 433
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability 432
Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons 432
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 432
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors 431
Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease 430
Deficits of glutamate transmission in the striatum of experimental hemiballism 430
Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses 429
Pathological synaptic plasticity in the striatum: implications for Parkinson's disease 429
Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors 429
Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery 428
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study 428
Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors 428
The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia 427
Transmitter release associated with long-term synaptic depression in rat corticostriatal slices 426
Engagement of rat striatal neurons by cortical epileptiform activity investigated with paired recordings 423
Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment 421
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease 421
Permissive role of interneurons in corticostriatal synaptic plasticity 419
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 419
Basic research in substantia nigra and ventral tegmental area: clinical implications 418
The modulation of dopamine receptors in rat striatum 416
SYNAPTIC PLASTICITY IN THE STRIATUM - ROLE OF GLUTAMATE AND DOPAMINE-RECEPTORS 416
Long-term potentiation and memory processes in the psychological works of Sigmund Freud and in the formation of neuropsychiatric symptoms 415
The modulation of calcium currents by the activation of mGluRs. Functional implications 415
Long-term Potentiation in the Striatum is Unmasked by Removing the Voltage-dependent Magnesium Block of NMDA Receptor Channels 413
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 412
Glutamate-triggered events inducing corticostriatal long-term depression 410
Chronic cocaine prevents depotentiation at corticostriatal synapses 410
Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum 410
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum 409
Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation 409
Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum 409
NR2B subunit exerts a critical role in postischemic synaptic plasticity 408
Electrophysiology of dopamine in normal and denervated striatal neurons 408
Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses 407
Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease 405
Impaired excitatory transmission in the striatum of rats chronically intoxicated with manganese 403
Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies 403
Totale 44.824
Categoria #
all - tutte 138.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.999


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.141 0 0 0 98 16 201 34 51 72 195 38 436
2022/20231.437 190 77 27 138 84 423 157 80 93 4 135 29
2023/2024344 32 13 37 8 32 113 15 27 2 5 0 60
2024/20253.324 83 805 356 189 50 197 240 73 244 191 531 365
2025/20264.548 354 313 514 359 388 134 450 650 493 523 221 149
2026/20271.752 255 274 957 266 0 0 0 0 0 0 0 0
Totale 66.506